Direkt zum Inhalt

Case details

Case Number: UPC_APP_52382/2023

  • Patent number:
    EP1856251 - METABOLICALLY ENGINEERED CELLS FOR THE PRODUCTION OF RESVERATROL OR AN OLIGOMERIC OR GLYCOSIDICALLY-BOUND DERIVATIVE THEREOF

  • Proceeding type: Application

  • Action/Application: Inanspruchnahme der Ausnahmeregelung

  • Applicants:
    Novagraaf Technologies Represented by Marie-Noelle de la Fouchardiere

  • Court Division: appealInstance - seat - Luxembourg

  • Date of Formal receipt: 2023-04-27 16:06:09